RNU)>F$J1=9F,^U+BJ^YSSYGAU=#D'.IL(A#V!*W/N:][QT
SYSTEM PROCESSING...
RNU)>F$J1=9F,^U+BJ^YSSYGAU=#D'.IL(A#V!*W/N:][QT
SYSTEM PROCESSING...
Posted: 2025-04-12 18:14:13 UTC
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
Status
Last Updated
2025-04-12 18:14:41 UTC
Verified By
Rollup News
The gut microbiome influences brain function through immune, neuroendocrine, and neurotransmitter pathways. Gut dysbiosis is linked to depression via HPA axis dysregulation, leaky gut, neuroinflammation, LPS, kynurenine pathway activation, SCFAs, microbial modulation of neurotransmitters, and vagal signaling. Psychobiotics and BDNF modulation show therapeutic potential.
Gut microbiota influences brain function
Gut dysbiosis linked to depression
HPA axis dysregulation and microbiome
Leaky gut and neuroinflammation
LPS and kynurenine pathway activation
SCFAs modulate neuroinflammation and neurogenesis
Microbial modulation of neurotransmitters
Vagal signaling in mood regulation
Therapeutic potential of psychobiotics
Microbiome profiles in depressive disorders
BDNF as a mediator of antidepressant effect
Strain-specificity of probiotics
Dosing of probiotics
Heterogeneity of effect of probiotics
Reduced microbial diversity in depression
Distinct taxonomic shifts in depression